Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockDiscovery themes featuring this stock
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Jubilant Ingrevia Ltd (JUBLINGREA) is currently trading at 624.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Jubilant Ingrevia is a global player in Specialty Chemicals, CDMO, Nutrition & Health Solutions serving diverse industries. Its diversified product portfolio includes pyridine derivatives, fine chemicals, pharma, and agro intermediates. The company is prioritizing expansion, evidenced by new plant constructions aimed at boosting production in agrochemical and specialty chemicals sectors. This will support increased demand and strategic growth expectations. FTAs signed with major regions are anticipated to increase its competitive footing in the US and EU markets, aligning its strategic ambitions with global trade dynamics. Despite global pricing pressures, the company maintains strong operational resilience, leveraging volume growth and strategic cost optimization to sustain stable performance. Jubilant Ingrevia is also focusing on emerging segments like semiconductors and AI-applications, positioning itself strategically in high-growth innovation spaces.
Over the past 52 weeks, Jubilant Ingrevia Ltd has traded between a low of ₹535.30 and a high of ₹851.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Jubilant Ingrevia Ltd has a market capitalization of approximately 9,857.91. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Jubilant Ingrevia Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 35.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 9,857.91 Cr, Jubilant Ingrevia Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Jubilant Ingrevia Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Jubilant Ingrevia Ltd is 35.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Management said incremental growth is increasingly coming from Specialty Chemicals, including Fine Chemicals and CDMO, which have delivered EBITDA margins of 24–26% and a reported 12% revenue growth with 26% margins.
Revenue in Q4FY25 was ₹1,051 crore versus ₹1,074 crore in Q4FY24, a year-on-year decline of 2.14%.
The stock fell 6.5% in the past week versus the Sensex’s 3.84% drop, and it is down 21.17% YTD compared with a 7.16% fall in the Sensex.
Bearish
4
Neutral
3
Bullish
7
Bearish
29
Neutral
3
Bullish
14
Bearish
25
Neutral
0
Bullish
7
Jubilant Ingrevia is a global player in Specialty Chemicals, CDMO, Nutrition & Health Solutions serving diverse industries. Its diversified product portfolio includes pyridine derivatives, fine chemicals, pharma, and agro intermediates.
The company is prioritizing expansion, evidenced by new plant constructions aimed at boosting production in agrochemical and specialty chemicals sectors. This will support increased demand and strategic growth expectations.
FTAs signed with major regions are anticipated to increase its competitive footing in the US and EU markets, aligning its strategic ambitions with global trade dynamics.
Despite global pricing pressures, the company maintains strong operational resilience, leveraging volume growth and strategic cost optimization to sustain stable performance.
Jubilant Ingrevia is also focusing on emerging segments like semiconductors and AI-applications, positioning itself strategically in high-growth innovation spaces.
Chemicals & Petrochemicals
Specialty Chemicals
9,858 Cr
High Risk
35.5
42.3
1.3
3.2
851.85
535.30
Sales CAGR
Profit CAGR
ROE
ROCE
Tax Order
Commissioner CGST (Appeals), Meerut passed a favorable order (dated May 26, 2026; received June 8, 2026) setting aside service tax on ocean freight (basic ₹36,04,971, penalty ₹36,04,971) and applicable interest for FY 2017‑18, removing the contingent liability.
Favourable Tax Order
Commissioner CGST (Appeals), Meerut set aside service tax demand, penalty and interest for FY 2017‑18 on ocean freight (tax ₹36,04,971; penalty ₹36,04,971), removing the contingent liability; order dated May 26, 2026, received June 8, 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
3248.00 | 12,643 Cr | 38.60 | 8.95 | 0.31 | 23.19 | 21.43 | 9.99 | ||
620.00 | 9,858 Cr | 35.47 | 3.15 | 0.40 | 8.89 | 10.37 | 5.07 | ||
1808.35 | 9,250 Cr | 51.39 | 6.03 | 0.55 | 11.74 | 15.60 | 9.50 | ||
740.00 | 7,877 Cr | 34.30 | 4.97 | 0.54 | 14.50 | 19.52 | 12.88 | ||
9300.00 | 7,381 Cr | 50.55 | 7.32 | 0.08 | 14.66 | 19.67 | 12.52 | ||
2068.25 | 6,661 Cr | 39.84 | 3.37 | 0.54 | 8.46 | 11.24 | 6.17 | ||
527.15 | 6,580 Cr | 61.87 | 3.40 | 0.47 | 5.52 | 7.20 | 3.96 | ||
| Median: 7 Co. | — | 1808.35 | 7,877 Cr | 39.84 | 4.97 | 0.47 | 11.74 | 15.60 | 9.50 |
